Search SAMHSA Publications and Digital Products
Store Facets Summary
Main page content
Published: August 2021
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Published: July 2021
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Addressing Suicidal Thoughts and Behaviors in Substance Abuse Treatment: Quick Guide for Clinicians Based on TIP 50
Published: November 2013
This quick guide helps clinicians and other service providers address suicide and suicide prevention in patients living with substance use disorders. It covers risk factors and warning signs for suicide, core competencies, and information for administrators and clinical supervisors.
Published: December 2011
This manual assists behavioral health professionals who treat people living with substance use disorders in understanding the implications of a hepatitis diagnosis. It discusses screening and referrals, and explains how to evaluate a program's hepatitis practices. Access the literary review.